Universal Marketing Associates,s.a Pharmaceutical Import Profile — Nicaragua (DGFT 2022–2026)

Name: Universal Marketing Associates,s.a Pharmaceutical Import Records from India — 2 Products, $120.2K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Universal Marketing Associates,s.a — Pharmaceutical Importer Profile (2026) | 2 Products, $120.2K Trade | TransData Nexus

Universal Marketing Associates,s.a

Pharmaceutical Importer · Nicaragua · Combination Drugs Focus · $120.2K Total Trade · DGFT Verified

Universal Marketing Associates,s.a is a pharmaceutical importer based in Nicaragua with a total trade value of $120.2K across 2 products in 2 therapeutic categories. Based on 6 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Universal Marketing Associates,s.a sources from 2 verified Indian suppliers, with Vardhman Exports accounting for 94.8% of imports.

Universal Marketing Associates,s.a — Import Portfolio & Supplier Network

Universal Marketing Associates,s.a import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Universal Marketing Associates,s.a?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Vardhman Exports	$169.8K	7	94.8%
Medorbis Trade Llp	$9.3K	1	5.2%

Universal Marketing Associates,s.a sources from 2 verified Indian suppliers across .

What Formulations Does Universal Marketing Associates,s.a Import?

Formulation	Value	Ships
Calcio 600 tablets	$60.5K	3
Acetylsalicylic acid tablets 100 MG 100 x	$59.4K	2
Atenolol tablets BP 100 MG	$43.4K	1
Leucovorin calcium injection USP 50MG/5ML (10000 vials)	$9.3K	1
Acetylsalicylic acid tablets 100 MG 10 x	$6.5K	1

Universal Marketing Associates,s.a imports 5 distinct pharmaceutical formulations. Showing top 5 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Acetylsalicylic	Combination Drugs	$66.0K	3	1.5%	13
2	Glibenclamide	Advanced Diabetes Medications	$54.3K	3	0.1%	11

Universal Marketing Associates,s.a imports 2 pharmaceutical products across 2 categories into Nicaragua totaling $120.2K.

Universal Marketing Associates,s.a — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Universal Marketing Associates, S.A., commonly known as Unimark, is a prominent pharmaceutical importer and distributor headquartered in Managua, Nicaragua. Established to meet the growing demand for quality healthcare products, Unimark plays a pivotal role in the Nicaraguan pharmaceutical supply chain. The company specializes in importing and distributing a diverse range of pharmaceutical formulations, including tablets, capsules, syrups, and injections, sourced primarily from India. This strategic focus enables Unimark to offer a comprehensive portfolio of finished pharmaceutical products to the Nicaraguan market.

Unimark's operations are characterized by a strong emphasis on quality assurance and regulatory compliance. The company collaborates closely with the Ministry of Health's Pharmaceutical Office to ensure that all imported products meet the stringent safety and efficacy standards required for distribution in Nicaragua. This commitment to quality has solidified Unimark's reputation as a reliable partner in the healthcare sector, catering to the needs of hospitals, clinics, pharmacies, and other healthcare providers across the country.

2Distribution Network

Unimark's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products throughout Nicaragua. The company's main warehouse is located in Managua, serving as the central hub for operations. From this location, Unimark employs a fleet of refrigerated and standard vehicles to transport products to various regions, ensuring timely and safe delivery. The distribution network covers urban and rural areas, facilitating access to essential medications for diverse populations. While the primary focus is on the Nicaraguan market, Unimark has also explored opportunities to extend its reach to neighboring countries, leveraging its logistical capabilities and established supplier relationships.

3Industry Role

In Nicaragua's pharmaceutical supply chain, Unimark functions as a primary wholesaler and distributor. The company imports finished pharmaceutical formulations from international suppliers, particularly from India, and distributes these products to various healthcare providers, including hospitals, clinics, and pharmacies. By acting as an intermediary between international manufacturers and local healthcare institutions, Unimark ensures the availability of a wide range of medications, thereby contributing to the overall health infrastructure of Nicaragua. The company's role is crucial in bridging the gap between global pharmaceutical innovations and local healthcare needs.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Universal Marketing Associates,s.a

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Unimark's sourcing strategy exhibits a high degree of concentration, with a significant majority of its pharmaceutical imports originating from India. Between 2022 and 2026, the company imported a total of $120,000 USD worth of pharmaceutical products from India, comprising six shipments. The top two products imported were Acetylsalicylic acid, valued at $66,000 USD, and Glibenclamide, valued at $54,000 USD. This concentration indicates a strategic choice to source from a single country, likely due to India's established reputation for producing high-quality, cost-effective pharmaceutical formulations.

The relationship stability with Indian suppliers appears strong, as evidenced by the consistent volume of imports over the years. The primary supplier, Vardhman Exports, accounted for 94.8% of the total import value, while Medorbis Trade LLP contributed 5.2%. This supplier concentration suggests a reliance on a limited number of partners, which could pose risks in the event of supply chain disruptions. However, the consistent import patterns also reflect a well-established and dependable sourcing relationship.

2Supply Chain Resilience

Unimark's supply chain resilience is closely tied to its sourcing strategy from India. The company's dependence on a limited number of suppliers, primarily Vardhman Exports and Medorbis Trade LLP, could expose it to risks such as supply disruptions or changes in supplier policies. To mitigate these risks, Unimark may consider diversifying its supplier base by exploring partnerships with additional manufacturers in India or other countries. Additionally, increasing the diversity of imported formulations could enhance supply chain flexibility and reduce dependency on specific products. Ensuring that all suppliers comply with international Good Manufacturing Practice (GMP) standards is essential to maintain product quality and regulatory compliance.

Importing Pharmaceuticals into Nicaragua — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nicaragua

1Regulatory Authority & Framework

In Nicaragua, the Ministry of Health's Pharmaceutical Office is the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. This office is responsible for issuing import permits, ensuring product safety and efficacy, and enforcing compliance with national health regulations. Key legislation governing pharmaceutical imports includes Law 292, the Medicines and Pharmacy Law, and Law 423, the General Health Law. These laws establish the legal framework for the registration, importation, and marketing of pharmaceutical products in Nicaragua. The registration process involves submitting comprehensive documentation to demonstrate product safety, efficacy, and quality, followed by evaluation and approval by the Ministry of Health.

2Import Licensing & GMP

Import licensing requirements in Nicaragua mandate that pharmaceutical products undergo a registration process with the Ministry of Health's Pharmaceutical Office. This process includes submitting detailed product dossiers, which may involve laboratory analysis fees. The recognition of Good Manufacturing Practice (GMP) certificates is crucial for ensuring product quality and compliance with international standards. Certificates from recognized authorities such as the European Medicines Agency (EMA), World Health Organization (WHO), and Pharmaceutical Inspection Co-operation Scheme (PIC/S) are typically accepted. Additionally, wholesale distribution authorization is required to legally distribute pharmaceutical products within Nicaragua.

Universal Marketing Associates,s.a — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Unimark's product strategy focuses on importing pharmaceutical formulations that address prevalent health conditions in Nicaragua. The company's top imported products include Acetylsalicylic acid and Glibenclamide, which are commonly used for cardiovascular and diabetes management, respectively. This focus aligns with the significant burden of non-communicable diseases in the country, such as heart disease and diabetes. By prioritizing these therapeutic areas, Unimark aims to meet the critical healthcare needs of the Nicaraguan population, ensuring access to essential medications that improve health outcomes.

2Sourcing Profile

Unimark's sourcing strategy is centered on procuring generic pharmaceutical formulations from India, a country renowned for its robust pharmaceutical manufacturing sector. The company's preference for finished formulations over active pharmaceutical ingredients (APIs) allows for quicker market entry and ensures that products are ready for distribution upon arrival. India's compliance with international GMP standards and its competitive pricing make it an attractive sourcing destination for Unimark. This approach enables Unimark to offer a diverse range of high-quality pharmaceutical products to the Nicaraguan market.

3Market Positioning

Seller's Guide — How to Become a Supplier to Universal Marketing Associates,s.a

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Nicaraguan market by partnering with Unimark. The company's established distribution network and strong relationships with regulatory authorities provide a solid foundation

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Universal Marketing Associates,s.a

What products does Universal Marketing Associates,s.a import from India?

Universal Marketing Associates,s.a imports 2 pharmaceutical products across 2 categories. Top imports: Acetylsalicylic ($66.0K), Glibenclamide ($54.3K).

Who supplies pharmaceuticals to Universal Marketing Associates,s.a from India?

Universal Marketing Associates,s.a sources from 2 verified Indian suppliers. The primary supplier is Vardhman Exports (94.8% of imports, $169.8K).

What is Universal Marketing Associates,s.a's total pharmaceutical import value?

Universal Marketing Associates,s.a's total pharmaceutical import value from India is $120.2K, based on 6 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Universal Marketing Associates,s.a focus on?

Universal Marketing Associates,s.a imports across 2 categories. The largest: Combination Drugs (54.9%), Advanced Diabetes Medications (45.1%).

Get Full Universal Marketing Associates,s.a Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.